Jiang Xiaomeng: A Centennial Enterprise with Craftsman Spirit
Release time:
2020-07-31
Editor's Note: days ago, the United Front Work Department of Jinhua Municipal Committee, the Municipal Federation of Industry and Commerce and other units jointly launched a large-scale publicity campaign on "2016 Letter to Good Wu Merchants". 10# June 18 , Jinhua media reporters walked into the peak and made a collective interview with Chairman Jiang Xiaomeng. 10# October 21 , the front page of Jinhua Daily published the article "Jiang Xiaomeng: Strive for a Century of Enterprise with Craftsman Spirit" written by its reporter Zhang Shuai. This newspaper is reproduced.
58 , Chairman Jiang Xiaomeng's face is filled with passion and confidence.
58 years, the peak has experienced ups and downs. Every time it encounters a major turning point, generations of "peak people" have opened a new chapter with tireless efforts and simple wisdom.
11.03 .6 billion yuan, up 4.15% over the same period of last year; Net profit attributable to owners of the parent company reached 1.03 billion yuan, up 12.9 year on year. These data in the current weak domestic economic development, has become more prominent.
58 years, and are also the models of our "wushang" group to stick to industry, operate in good faith and serve the country by industry.
58 years ago, bearing in mind the history of the peak, can be seen at a glance by many old Jin Chinese. This is the original site of the Wisdom Temple in the north of Jinhua City. The place was small and desolate. The first group of pioneers built the first cement factory in Jinhua with their hands and blood.
20 years old, he walked into the gate of the cement factory and is now leading thousands of people to fight the business world. Jiang Xiaomeng said that this is the common growth and achievement of individuals and enterprises. 1993
28 , unusual for Jianfeng Group. On this day, Jianfeng stock started trading on the Shanghai Stock Exchange and became the country's first listed company in the cement industry, which laid the foundation for the standardized management and further development of Jianfeng Group. to 2006
2007 , the cement market competition is extremely fierce, coupled with the state's policy restrictions on the closure of mechanical vertical kilns, many cement plants have lost their competitiveness. Spikes are also facing harsh realities, and benefits are plummeting. At this key node, Jianfeng cooperated with central enterprises in a timely manner to transfer the equity of cement enterprise 65% in Zhejiang Province, set up Southern Cement, became one of the sponsors of Southern Cement, and invested limited funds in the central and western regions with more advantages in market prospects, resources and supply. After the most difficult period from 2006 to
, Jianfeng promptly established the development policy of "strengthening the main business through cooperation and innovation, standardizing science and seeking development", and became an industrial pattern with cement and medicine as the two main businesses, bonded logistics as the supplement, and multiple investments in concentric related industries as the supplement, which further clarified the industrial positioning of the group, be a niche in the cement market, a leader in the pharmaceutical industry segment, and a leader in health product innovation. Jiang Xiaomeng said that these decisions are strategic choices made in combination with the actual situation of the peak and the development trend, and are the self-adjustment of the peak group on the road of development. Only when the positioning is accurate and the goal is clear can an enterprise have the driving force for sustainable development.
Looking forward to the future, driven by innovation in medicine and health, the industry is booming
. Besides complementing cement and having a broad market, Jiang Xiaomeng hopes to stimulate the vitality of the peak through medicine and health.
During the peak years of
, Jiang Xiaomeng knew very well that innovation and development are the best catalysts for enterprises to maintain vitality. To be brave, transformation and upgrading are the best driving forces. The medical and health industry is also one of the most obvious industries driven by scientific and technological innovation. Jianfeng Pharmaceutical has always paid attention to the innovative research and development of pharmaceutical products. It has two professional research institutions and a provincial new drug research and development center. At the same time, it has
academician expert workstations and 3 postdoctoral mobile stations in the field of plant extracts and chemical pharmaceuticals respectively, and has obtained more than 20 national invention patents . This has laid a solid foundation for the innovation of peak pharmaceutical products. Many products of Jianfeng Pharmaceutical have been listed as national high-tech industrialization demonstration project, national key new product plan project and national torch plan project, and have been rated as national high-tech enterprises for 10 years in a row. In addition, with the deepening of the management of pharmaceutical commercial circulation order, the peak will effectively integrate the existing internal circulation enterprises in the field of circulation, and constantly improve the profitability and business model with innovative thinking, so as to make the pharmaceutical circulation enterprises more standardized, more orderly and stronger, and further enhance their competitiveness. Jianfeng Health Technology Co., Ltd. is another major layout of Jianfeng Group in the field of health in recent years. Entering the company's laboratory, high-tech experimental equipment can be seen everywhere. In front of a piece of equipment, Yu Hongjian, general manager of the Health Technology Company, told reporters that this is the first production equipment used in ginkgo extract in China. The entire production process is operated and monitored in real time by the computer system in the central control room to minimize Human errors and risks ensure stable and safe product quality. In the central control room, the reporter also saw two staff members staring at the large computer screen all the time, paying attention to the changes in the monitoring values on the screen.
In the Peak Health Experience Hall, Jiang Xiaomeng introduced that the big health industry is a very broad concept, including health care products, health care for the aged, health care, etc. With the improvement of people's living conditions, people's demand will be more and more big. The human demand for health, health care and longevity is an irreversible trend and trend. The positioning of the peak for the big health industry is: natural raw materials, ancient and modern use, changing tradition into fashion, and being a leader in health product innovation. Around this concept, Spike has done a lot of work in innovative decoction pieces and has obtained a number of patents, for example, many people know that eating Gastrodia elata is good, but the texture of Gastrodia elata is hard, how to eat it? Spike Health makes Gastrodia elata slices that dehydrate and freeze-dry slices of fresh Gastrodia elata, which is as simple and convenient as eating potato chips. There are also freeze-dried ultra-fine powder of noto-ginseng, freeze-dried Dendrobium, heart-shaped Astragalus tablets and so on.
listed
years, Jianfeng Group's total assets have increased from 1.38 .2 billion yuan at the beginning of listing to 35.78 .4 billion yuan now, and its net assets have increased from less than 1 .6 billion yuan to 22.01 .8 billion yuan, increasing nearly 26 times and 22 times respectively. operates in good faith, sticks to industry, and does not forget social responsibility
In the Jianfeng History Showroom, photos with historical accumulation make people feel that Jianfeng Group is working hard and at the same time, they also see Jianfeng's active social responsibility. Since the listing of
, the peak tax payment and social security payment have exceeded
.3 billion yuan, which has been a major taxpayer of enterprises in Jinhua for many years. Jianfeng Group, Jianfeng Pharmaceutical, Jianfeng Cement and other holding companies were rated as Zhejiang Province 3A -class contract-abiding and trustworthy units, integrity management enterprises. Jianfeng Group has just won the silver award of "Zhejiang Industry Award" in 2016 this year, and is the second batch of "three" cultivation pilot enterprises in Zhejiang Province. Jianfeng Group has also carried out fruitful work in enterprise pairing, thousand enterprise pairing, and employee labor security. It has been rated as an advanced ideological and political work unit in Zhejiang Province and Jinhua City for many years. started from
April with a donation of of 20 .56 million yuan to build "Zhejiang Jianfeng Hope Primary School" (the first Hope Primary School on the "Roof of the World" aided by an enterprise) in Nagqu District of Tibet Autonomous Region. Jianfeng Group's "Hope" road lasted for 21 years. In the meantime, 8 Hope Primary School, which was built with high-end donations, has sprung up. Its donation areas cover Tibet, Gansu, Yunnan and our Jinhua region.
.5 billion yuan in environmental protection technological transformation funds exceeding . Because ecological development has been implanted into corporate culture, many important activities can always see the figure of the peak, such as Jinhua five water co-governance, Wenchuan earthquake relief, Jinhua Red Cross donation AED automatic defibrillator and so on.
58 years, in addition to the upbringing of Jinhua, is also because the peak development has four cornerstones: a strong corporate culture, a development path suitable for itself, and an endogenous expansion desire that matches its own strength, there is a management team that highly identifies with the culture of spikes. "Our mission is to be a century-old peak, and generations of peak people will dream of the future with the spirit of craftsmen." ("Jinhua Daily" reporter Zhang Shuai)
More information
Two Cement Enterprises Prosperous Production and Sales in May
With the gradual easing of the new crown epidemic, all over the project has started, Hubei, Yunnan two provinces cement market continued to improve, Daye peak cement company, Yunnan peak cement company two enterprises have recently shown a good momentum of production and sales. In May, the sales volume of Yunnan Jianfeng cement continued to rise. As of the time of publication, the average daily shipment volume reached more than 7400 tons, and the highest daily shipment volume reached more than 8700 tons, and the production capacity was fully released. Over the past few days, Yunnan Peak Packaging System has made great efforts to overcome the impact of narrow distribution sites and many cement varieties to ensure the completion of delivery tasks with good quality and quantity every day. In order to further balance production and sales and create conditions for the homogenization of cement delivered from the factory, Yunnan peak packaging system puts forward work requirements for relevant posts, emphasizes equipment inspection and process inspection during production, strictly implements safety operation procedures, and maintains safe and efficient operation of the system. Due to the impact of the new crown epidemic, Hubei cement market started late, Wuhan market is the hardest hit area, the current project construction is still not fully started, the volume pressure is greater. For this reason, daye peak departments cooperate closely, increase market development efforts, develop new mixing stations, focus on increasing the bulk share of Xianning, Huanggang and Wuhan markets, seize the opportunity of fine weather, and achieve the goal of rapid output. Internally, on the basis of equipment technical renovation and production capacity improvement, the delivery is effectively guaranteed, and the daily delivery capacity can basically be maintained at 10,000 tons. In May, Daye Peak sold more than 300000 tons of cement, an increase of 20% over the same period last year, with an average daily sales volume of more than 9900 tons, the highest in the current period since Daye Peak was put into production.
2020
07-31
The company's "safe production month" activities are about to start
June 2020 is the 19th national "safe production month", the theme of the activity is "eliminating hidden dangers of accidents and building a strong line of defense". A few days ago, the group company issued a notice to arrange the activities related to the organization of "safe production month" and put forward requirements. According to the group's "safe production month" activity plan, different key thematic activities will be held in the four weeks of June. The first week is the "Publicity and Safety Education Week", which focuses on the use of WeChat groups, electronic screens, publicity boards, banners, slogans and other forms for safety publicity, and organizes the study of national safety regulations, company safety system specifications and accident-free factory creation standards, Organize to watch safety warning education films, learn accident cases, etc., and improve employees' safety awareness by creating a safety atmosphere and organizing learning activities. The focus of the activities in the second week is "looking for potential sources of danger around you". Each unit takes departments and teams as units to investigate and analyze the potential risk factors in the process of daily production, maintenance and operation, find out the hazard sources that have not been included in the scope of risk point control, and report to the safety management department of the unit to form a risk assessment report, put forward solutions or suggestions, and supervise the implementation of rectification and timely eliminate potential safety hazards. The third week is the "on-site safety innovation achievements exhibition week", which focuses on the achievements of each unit in on-site safety management and on-site safety facilities in the past year, which are displayed in the form of pictures and texts through beautiful articles and wechat, so as to learn from each other and promote common progress. The fourth week is the "safety training and drill week", and the group company organizes the standardization of safety production and the elimination of hidden dangers.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-30
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-22
On April 24, Jiang Xiaomeng, chairman of the group company, presided over the 14th meeting of the 10th board of directors of the company, and deliberated and passed 14 related reports and motions such as the 2019 annual board of directors report, the 2019 general manager business report and the 2019 annual report. The general manager's report pointed out that 2019 is the first year of the implementation of the group's new five-year strategic development plan (2019-2023) and the new three-year business plan (2019-2021) for each business sector. the management team has carried out various operation and management work in an orderly manner around the general policy of "innovation and reform, integration and promotion, scientific layout and steady development", and has better completed the business objectives set by the board of directors at the beginning of the year. In the whole year, the company achieved a total operating income of 3.548 billion billion yuan, an increase of 5.51 percent over the same period last year; net profit attributable to shareholders was 0.725 billion billion yuan, with earnings per share reaching 2.11 billion yuan, an increase of 23.14 percent over the same period last year, a record high; total assets at the end of the year were 5.475 billion billion yuan, an increase of 11.71 percent over the same period last year; and net assets attributable to shareholders were 3.789 billion billion yuan, an increase of 19.81 percent. During the reporting period, the company's two main businesses have achieved great development, benefiting from the further promotion of supply-side structural reform, the overall operation of the cement industry in 2019 is stable, and the industry benefits are further improved. During the reporting period, the company made new progress in the construction of cement projects, completed the acquisition, capital increase and name change of Guizhou Mingchuan (Guizhou Huangping Jianfeng Cement Co., Ltd.), and continued to invest in the construction of its new dry cement production line with a daily output of 4500 tons of clinker.
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page